The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jul. 16, 2019
Filed:
Oct. 30, 2015
Applicant:
University of Utah Research Foundation, Salt Lake City, UT (US);
Inventors:
You Han Bae, Salt Lake City, UT (US);
Yong-Kyu Lee, Chngbuk, KR;
Md Nurunnabi, Chungbuk, KR;
Hee Sook Hwang, Salt Lake City, UT (US);
Dongsub Kwag, Seoul, KR;
Assignee:
UNIVERSITY OF UTAH RESEARCH FOUNDATION, Salt Lake City, UT (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 9/51 (2006.01); A61K 9/16 (2006.01); A61K 9/50 (2006.01); A61K 38/26 (2006.01); A61K 38/28 (2006.01); A61K 31/704 (2006.01); A61K 47/54 (2017.01); A61K 47/59 (2017.01); A61K 47/61 (2017.01); A61K 47/64 (2017.01); A61K 47/18 (2017.01); A61K 47/34 (2017.01); A61K 47/46 (2006.01); A61K 31/00 (2006.01); A61K 9/127 (2006.01); A61K 9/19 (2006.01);
U.S. Cl.
CPC ...
A61K 9/1652 (2013.01); A61K 9/5036 (2013.01); A61K 9/5123 (2013.01); A61K 9/5161 (2013.01); A61K 9/5169 (2013.01); A61K 31/00 (2013.01); A61K 31/704 (2013.01); A61K 38/26 (2013.01); A61K 38/28 (2013.01); A61K 47/18 (2013.01); A61K 47/183 (2013.01); A61K 47/34 (2013.01); A61K 47/46 (2013.01); A61K 47/554 (2017.08); A61K 47/59 (2017.08); A61K 47/61 (2017.08); A61K 47/645 (2017.08); A61K 47/6455 (2017.08); A61K 9/1272 (2013.01); A61K 9/1278 (2013.01); A61K 9/19 (2013.01);
Abstract
Therapeutic compositions are disclosed which contain a therapeutic agent and a bile acid or bile acid conjugate. The compositions can be absorbed via enterohepatic circulation. The compositions include a cationic moiety and an anionic polymer, which are coupled through electrostatic interactions. The therapeutic compositions can be used for the treatment of diseases or disorders.